aTyr Pharma Inc Stock
aTyr Pharma Inc Stock
aTyr Pharma Inc took a tumble today and lost -€0.025 (-3.290%).
Our community identified positive and negative aspects for aTyr Pharma Inc stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the aTyr Pharma Inc stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of aTyr Pharma Inc in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of aTyr Pharma Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| aTyr Pharma Inc | -3.290% | -6.962% | 26.724% | -80.759% | 22.500% | -62.982% | -79.354% |
| Larimar Therapeutics Inc. | -1.720% | 83.200% | 51.656% | 68.382% | 37.952% | -21.034% | -67.518% |
| Vaxart Inc. | 0.000% | 27.907% | 12.245% | 15.692% | 96.429% | -29.487% | -90.678% |
| Celldex Therapeutics | -0.780% | 29.293% | 15.315% | 29.949% | 16.364% | -40.019% | 14.082% |